1
0
0
(1 - 14 von 15
)
Browse by People - ePrints Soton - University of SouthamptonePrints Soton
eprints.soton.ac.uk
... Günter Fingerle-Rowson, Kaspar Rufibach, Tom Moore, Michael Herold and Wolfgang Hiddemann. Type: Article | | Item not available on this server. This Günter Fingerle-Rowson, Kaspar Rufibach, Tom Moore, Michael Herold and Wolfgang Hiddemann. Type: Article | | Item not available on this server. This ...
Original Article Obinutuzumab for the First-Line Treatment ...The New England Journal of Medicine
www.nejm.org
B., Marek Trněný, M.D., Michael Wenger, M.D., Günter Fingerle-Rowson, M.D., Ph.D., Kaspar Rufibach, Ph.D., Tom Moore, M.B., Ch.B., Michael Herold, M.D., and ... B., Marek Trněný, M.D., Michael Wenger, M.D., Günter Fingerle-Rowson, M.D., Ph.D., Kaspar Rufibach, Ph.D., Tom Moore, M.B., Ch.B., Michael Herold, M.D., and ...
Publications matching author Günter Fingerle-RowsonMinso Solutions AB
ci.minso.se
... Günter Fingerle-Rowson 1, Matthias Ritgen 1, Michael Kneba 1, Hartmut Döhner 1, Stephan Stilgenbauer 1, Wolfram Klapper 1, Clemens-Martin Wendtner Günter Fingerle-Rowson 1, Matthias Ritgen 1, Michael Kneba 1, Hartmut Döhner 1, Stephan Stilgenbauer 1, Wolfram Klapper 1, Clemens-Martin Wendtner
Obinutuzumab or Rituximab Plus Cyclophosphamide, ...Swiss Open Access Repository
sonar.ch
von U Vitolo · · Zitiert von: 420 — Oestergaard, Günter Fingerle-Rowson, Olivier Catalani, and Tina Nielsen, F. Hoffman-La Roche, Basel, Switzerland; and Michael Wenger ... von U Vitolo · · Zitiert von: 420 — Oestergaard, Günter Fingerle-Rowson, Olivier Catalani, and Tina Nielsen, F. Hoffman-La Roche, Basel, Switzerland; and Michael Wenger ...
DFG - GEPRIS - Analysis of macrophage migration …
gepris.dfg.de
WebJahrestagung der DGHO, ÖGHO, SGMO und SGH, 2008, Wien Tania M. Brocks, Astrid Stein, Hans-Peter Dienes, Michael Hallek, Günter Fingerle-Rowson A tautomerase …
Rapid and transient activation of the ERK MAPK signalling ...TUM
portal.fis.tum.de
Hongqi Lue, Aphrodite Kapurniotu, Günter Fingerle-Rowson, Thierry Roger, Lin Leng, Michael Thiele, Thierry Calandra, Richard Bucala, Jürgen Bernhagen. Hongqi Lue, Aphrodite Kapurniotu, Günter Fingerle-Rowson, Thierry Roger, Lin Leng, Michael Thiele, Thierry Calandra, Richard Bucala, Jürgen Bernhagen.
Minimal Residual Disease Quantification Is an ...Case Western Reserve University
nlp.case.edu
— ... Günter Fingerle-Rowson, Anna Maria Fink, Clemens-Martin Wendtner, Barbara F. Eichhorst, and Michael J. Hallek, University of Cologne — ... Günter Fingerle-Rowson, Anna Maria Fink, Clemens-Martin Wendtner, Barbara F. Eichhorst, and Michael J. Hallek, University of Cologne ...
FCR Regimen | Citations | Top Authors | Related Topicstypeset.io › Topic Directory
typeset.io
Michael Hallek 1, Kirsten Fischer 1, Günter Fingerle-Rowson 1, Anna-Maria Fink 1, Raymonde Busch, Jiří Mayer, Manfred Hensel 2, Georg Hopfinger, G D Hess 3, ...
Minimal Residual Disease Quantification Is an Independent ...国立情報学研究所
cir.nii.ac.jp
Sebastian Böttcher, Matthias Ritgen, and Michael Kneba, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel; Kirsten Fischer, Günter Fingerle-Rowson, ...
Obinutuzumab or Rituximab Plus Cyclophosphamide, ...Medpage Today
clf1.medpagetoday.com
von U Vitolo · · Zitiert von: 356 — Tatsumi, Mikkel Z. Oestergaard, Michael Wenger, Günter Fingerle-Rowson, Olivier Catalani, Tina Nielsen,. Maurizio Martelli, and Laurie H.
Pharmacokinetics, exposure, efficacy and safety of ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von E Gibiansky · · Zitiert von: 4 — Authors. Ekaterina Gibiansky , Leonid Gibiansky , Vincent Buchheit , Nicolas Frey , Michael Brewster , Günter Fingerle-Rowson , Candice Jamois ... von B Mathew · · Zitiert von: 48 — ... Huey,1 Aydogan Bulent,5 Brett Smith,5 Sundararajan Jayaraman,1,2 Narsa M. Reddy,3 Shekhar P. Reddy,3Günter Fingerle-Rowson,6 Richard Bucala,7 Steven M.
Obinutuzumab for the first-line treatment of follicular lymphomaeprints.soton.ac.uk › ...
eprints.soton.ac.uk
· Author: Günter Fingerle-Rowson. Author: Kaspar Rufibach. Author: Tom Moore. Author: Michael Herold. Author: Wolfgang Hiddemann ...
FC-R vs. FC in der Erstlinientherapie der CLL (Update ...ONKODIN
www.onkodin.de
— Michael Hallek, Guenter Fingerle-Rowson, Anna-Maria Fink, Raymonde Busch, Jiri Mayer, Manfred Hensel, Georg Hopfinger, Georg Hess, ...
Obinutuzumab for the First-Line Treatment of Follicular ...x-mol.com
www.x-mol.com
— ... Marek Trněný , Michael Wenger , Günter Fingerle-Rowson , Kaspar Rufibach , Tom Moore , Michael Herold , Wolfgang Hiddemann ...
Alle Infos zum Namen "Günter Fingerle-Rowson"
Verwandte Suchanfragen zu Günter Fingerle-Rowson
| Marcel Wolbers Andreas Meinhardt Kirsten Fischer | Philipp Lacher Clemens-Martin Wendtner Dominik Schumacher | Jörg Klug Suada Fröhlich Kaspar Rufibach |
Personen Vorname "Günter" (29119) Name |
sortiert nach Relevanz / Datum